Goldman Sachs Group »

Caris Life Sciences shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.5M 282k 30.25

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
Spdr S&p 500 Etf Tr CMN (SPY)
Microsoft Corp CMN (MSFT)
Apple CMN (AAPL)
Invesco Qqq Tr CMN Put Option (QQQ)
Tesla CMN (TSLA)
Amazon CMN (AMZN)
Meta Platforms CMN (META)
Alphabet CMN (GOOGL)
Broadcom CMN (AVGO)
Ishares Tr CMN (IVV)
Ishares Tr CMN Put Option (IWM)
Vanguard Index Fds CMN (VOO)
Ishares Tr CMN Put Option (HYG)
Jpmorgan Chase & Co. CMN (JPM)

View all positions for Goldman Sachs Group

Top funds holding Caris Life Sciences

Sixth Street Partners Management Company
Coatue Management
FMR
T. Rowe Price Investment Management
Braidwell
Silver Lake Group
Neuberger Berman Group
Millennium Management
PointState Capital
OrbiMed Advisors
Ameriprise Financial
ClearBridge Advisors
Canada Pension Plan Investment Board
Alliancebernstein
Ubs Global Asset Management Americas

View all funds holding Caris Life Sciences